TIS 0.00% 0.0¢ tissue therapies limited

Well done Steve and team !, page-5

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    We can but hope Surfrat.

    It would seem likely that a "List of Outstanding Issues" is just that. In other words it would be unfair if EMA raised new issues at the next meeting which were not raised in the initial "List of Questions". That means that if TIS has performed due diligence and dotted every i and crossed every t from the original List of Questions then there should be no further delays and a positive opinion, subsequent granting of CE Mark and first sales should be in late September / early October.

    Of course I'm trying to apply logic here to a process that may not be logical and may be subject to other influences.

    Rev
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.